Blood Purification in Non-Renal Critical Illness
- 22 January 2003
- journal article
- review article
- Published by S. Karger AG in Blood Purification
- Vol. 21 (1) , 6-13
- https://doi.org/10.1159/000067862
Abstract
Extracorporeal therapies designed to remove substances from the circulation now include hemodialysis, hemofiltration, hemoadsorption, plasma filtration, cell-based therapies and combinations of any of the above. In recent years, there have been considerable advances in our understanding and technical capabilities, but consensus over the optimal way, and under what conditions to use these therapies does not exist. Consequently, we have initiated a series of conferences under the auspices of the Acute Dialysis Quality Initiative (ADQI). ADQI aims at establishing an evidence-based appraisal and set of consensus recommendations to standardize care and direct further research. The results of previous consensus conferences are available on-line at www.ADQI.net. ADQI conferences have focused on research and management of renal disease. However, extracorporeal therapies are being used or investigated in the management of many other disease processes including systemic inflammation, liver disease, cardiac disease and thrombotic diseases.Keywords
This publication has 10 references indexed in Scilit:
- A pilot study of coupled plasma filtration with adsorption in septic shock*Critical Care Medicine, 2002
- Intensive Care Unit Management of the Critically Ill Patient with Fluid Overload after Open Heart SurgeryCardiology, 2001
- Coupled plasma filtration-adsorption in a rabbit model of endotoxic shockCritical Care Medicine, 2000
- The inflammatory balance in human sepsisIntensive Care Medicine, 2000
- Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical frameworkCritical Care Medicine, 2000
- Long-term results of overlapping anterior anal-sphincter repair for obstetric traumaThe Lancet, 2000
- Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?Intensive Care Medicine, 1999
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999
- Diffusive vs. convective therapyCritical Care Medicine, 1998
- Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swineCritical Care Medicine, 1998